These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35993946)

  • 1. Comprehensive Analysis of Tumor Immune Microenvironment and Prognosis of m6A-Related IncRNAs in Lung Adenocarcinoma.
    Shen Y; Hou N; Han F; Chen B; Shi J; Sun X
    Crit Rev Eukaryot Gene Expr; 2022; 32(5):77-91. PubMed ID: 35993946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
    Zhao J; Lin X; Zhuang J; He F
    Front Genet; 2021; 12():714697. PubMed ID: 34777460
    [No Abstract]   [Full Text] [Related]  

  • 3. Development and validation of the potential biomarkers based on m6A-related lncRNAs for the predictions of overall survival in the lung adenocarcinoma and differential analysis with cuproptosis.
    Gao C; Kong N; Zhang F; Zhou L; Xu M; Wu L
    BMC Bioinformatics; 2022 Aug; 23(1):327. PubMed ID: 35941550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of m6A modification patterns and m6A-related lncRNAs as potential biomarkers in lung adenocarcinoma.
    Wang S; Gu X; Xu D; Liu B; Qin K; Yuan X
    Environ Toxicol; 2024 Apr; 39(4):2285-2303. PubMed ID: 38148718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel m6A-Related LncRNA Signature for Predicting Prognosis, Chemotherapy and Immunotherapy Response in Patients with Lung Adenocarcinoma.
    Shen Y; Wang S; Wu Y
    Cells; 2022 Aug; 11(15):. PubMed ID: 35954243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comprehensive Analysis of the Relationship between m6A Methylation Patterns and Immune Microenvironment in Lung Adenocarcinoma].
    Ke J; Cui J; Yang X; Du X; Ma B; Yu L
    Zhongguo Fei Ai Za Zhi; 2022 May; 25(5):311-322. PubMed ID: 35599007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel algorithm for lung adenocarcinoma based on N6 methyladenosine-related immune long noncoding RNAs as a reliable biomarker for predicting survival outcomes and selecting sensitive anti-tumor therapies.
    Yan Q; Hu B; Chen H; Zhu L; Lyu Y; Qian D; Shao G
    J Clin Lab Anal; 2022 Sep; 36(9):e24636. PubMed ID: 35949000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
    Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
    BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H3K4me3-related lncRNAs signature and comprehensive analysis of H3K4me3 regulating tumor immunity in lung adenocarcinoma.
    Fan T; Zhu M; Muhammad S; Xiao C; Li S; Tian H; Liu Y; Xue L; Zheng B; Li C; He J
    Respir Res; 2023 May; 24(1):122. PubMed ID: 37131252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-6 methylation-related lncRNA is potential signature in lung adenocarcinoma and influences tumor microenvironment.
    Zheng J; Zhao Z; Wan J; Guo M; Wang Y; Yang Z; Li Z; Ming L; Qin Z
    J Clin Lab Anal; 2021 Nov; 35(11):e23951. PubMed ID: 34558724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of Immune Cell Infiltration of m6a-Related lncRNA in Lung Squamous Cell Carcinoma and Construction of Relevant Prognostic Models.
    Zhang P; Li H; Cheng X; Wang W
    Biomed Res Int; 2022; 2022():9139823. PubMed ID: 35872842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of RNA Methylation Modification-immune-related lncRNA Molecular Subtypes and Prognostic Scoring System in Lung Adenocarcinoma.
    Wang J; Shu J
    Curr Med Chem; 2024; 31(12):1539-1560. PubMed ID: 37680151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function and prognostic value of N6-methyladenosine-modified RNAs in lung adenocarcinoma.
    Liu J; Zheng Z; Zhong J
    J Gene Med; 2023 Jan; 25(1):e3454. PubMed ID: 36282144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of lncRNA-m6A gene-mRNA regulatory network to identify m6A-related lncRNAs associated with the progression of lung adenocarcinoma.
    Zhang J; Bai S; Yan Y; Kang H; Li G; Feng Z; Ma W; Wang X; Ren J
    BMC Pulm Med; 2023 Aug; 23(1):284. PubMed ID: 37537521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.
    Yu ZL; Zhu ZM
    Bioengineered; 2021 Dec; 12(1):1708-1724. PubMed ID: 33955330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of immune-related and prognostic lncRNA clusters and identification of their immune and genomic alterations characteristics in lung adenocarcinoma samples.
    Li J; Zhang C; Zhang C; Wang H
    Aging (Albany NY); 2020 May; 12(10):9868-9881. PubMed ID: 32445554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.
    Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J
    Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of N6-Methyladenosine Regulators on LAG3 and Immune Infiltrates in Lung Adenocarcinoma.
    Wang N; Xu Y; Jin L; Wang X; Wu S; Wang Y; Zhao J; Zhou F; Ge H
    Dis Markers; 2022; 2022():1829528. PubMed ID: 36051357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung.
    Miao H; Chen D; Li R; Hu J; Chen Y; Xu C; Wen Z
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33324975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.